Company Accounts and Tax Online 14973727 Board of Directors 1.8.24 31.7.25 31.7.25 No description of principal activity false iso4217:GBP xbrli:pure 14973727 2023-07-01 2024-07-31 14973727 2025-07-31 14973727 2024-08-01 2025-07-31 14973727 2024-07-31 14973727 countries:EnglandWales 2024-08-01 2025-07-31 14973727 curr:PoundSterling 2024-08-01 2025-07-31 14973727 uk-bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 14973727 uk-bus:Micro-entities 2024-08-01 2025-07-31 14973727 uk-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 14973727 uk-bus:FullAccounts 2024-08-01 2025-07-31 14973727 uk-bus:RegisteredOffice 2024-08-01 2025-07-31 14973727 uk-bus:Director1 2024-08-01 2025-07-31 14973727 uk-bus:Director1 2024-08-01 14973727 uk-bus:Director1 2025-07-31 14973727 core:AfterOneYear 2025-07-31 14973727 core:AfterOneYear 2024-07-31 14973727 core:WithinOneYear 2025-07-31 14973727 core:WithinOneYear 2024-07-31 14973727 core:WithinOneYear 2024-08-01 2025-07-31 14973727 core:AfterOneYear 2025-07-31 14973727 core:AfterOneYear 2024-07-31 14973727 core:AfterOneYear 2024-08-01 2025-07-31 14973727 core:ShareCapital 2025-07-31 14973727 core:ShareCapital 2024-07-31 14973727 core:RevaluationReserve 2025-07-31 14973727 core:RevaluationReserve 2024-07-31 14973727 core:RetainedEarningsAccumulatedLosses 2025-07-31 14973727 core:RetainedEarningsAccumulatedLosses 2024-07-31 14973727 1 2024-08-01 2025-07-31

# M.T.A. PHARMA LIMITED

## Company Registration Number:
14973727 (England and Wales)

## Unaudited micro entity accounts for the year ended 31 July 2025

## Period of accounts

## Start date: 01 August 2024

## End date: 31 July 2025

# M.T.A. PHARMA LIMITED

## Contents of the Financial Statements

for the Period Ended 31 July 2025

Company Information - 3 |
Balance sheet - 4 |
Footnotes to the Balance Sheet - 6 |

# M.T.A. PHARMA LIMITED

## Company Information

for the Period Ended 31 July 2025

Registered office: |  | 31 Long Barn Lane Reading England RG2 7SY
Company Registration Number: |  | 14973727 (England and Wales)

# M.T.A. PHARMA LIMITED

## Balance sheet

As at 31 July 2025

| 2025 £ | 13 months to 31 Jul 2024 £
--- | --- | ---
Called up share capital not paid: | 0 | 0
Fixed Assets: | 29,050 | 0
Current assets: | 6,783 | 5,643
Prepayments and accrued income: | 0 | 0
Creditors: amounts falling due within one year: | ( 23,000 ) | ( 0 )
Net current assets (liabilities): | ( 16,217 ) | 5,643
Total assets less current liabilities: | 12,833 | 5,643
Creditors: amounts falling due after more than one year: | ( 0 ) | ( 0 )
Provision for liabilities: | ( 0 ) | ( 0 )
Accruals and deferred income: | ( 0 ) | ( 0 )
Total net assets (liabilities): | 12,833 | 5,643
Capital and reserves: | 12,833 | 5,643

# M.T.A. PHARMA LIMITED

## Balance sheet continued

For the year ending 31 July 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 12 September 2025
And Signed On Behalf Of The Board By:

Name: Mohammed Talal Ahmed
Status: Director

The notes form part of these financial statements

# M.T.A. PHARMA LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 July 2025

- ## 1. Employee Information

  Average number of employees: 3

# M.T.A. PHARMA LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 July 2025

- ## 2. Off balance sheet disclosure

  No